0001179110-15-006097.txt : 20150408
0001179110-15-006097.hdr.sgml : 20150408
20150408161825
ACCESSION NUMBER: 0001179110-15-006097
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150406
FILED AS OF DATE: 20150408
DATE AS OF CHANGE: 20150408
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNTA PHARMACEUTICALS CORP
CENTRAL INDEX KEY: 0001157601
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 HARTWELL AVE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-274-8200
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gollust Keith R
CENTRAL INDEX KEY: 0001325712
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33277
FILM NUMBER: 15759279
MAIL ADDRESS:
STREET 1: C/O SYNTA PHARMACEUTICALS CORP.
STREET 2: 45 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
edgar.xml
FORM 4 -
X0306
4
2015-04-06
0
0001157601
SYNTA PHARMACEUTICALS CORP
SNTA
0001325712
Gollust Keith R
C/O SYNTA PHARMACEUTICALS CORP.
45 HARTWELL AVENUE
LEXINGTON
MA
02421
1
0
0
0
Common Stock
2015-04-06
4
P
0
350000
1.75
A
3173383
I
By Wyandanch Partners, L.P.
Common Stock
351766
D
Common Stock
175000
I
By Keith R. Gollust IRA
The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
/s/ Garrett M. Winslow, Attorney-in-Fact
2015-04-08